Indlela entsha yoNyango lweCannabis kuBantwana abaneAutism Spectrum Disorder 

A BAMBA isiKhululo sasimahla 8 | eTurboNews | eTN
IAvatar kaLinda Hohnholz
Ibhalwe ngu Linda Hohnholz

ICannformatics ibhengeze ukuba ichonge i-22 entsha enokubakho kwi-lipid-based Cannabis-Responsive™ biomarkers kumathe kubantwana abane-autism spectrum disorder (ASD). Zonke ii-biomarkers ezingama-22 ziye zatshintshela kuluhlu lwefiziyoloji yophuhliso lwabantwana abalandela unyango oluyimpumelelo lwe-cannabis. Ezi biomarkers ziquka inkqubo ye-nervous central lipids ezinxulunyaniswa ikakhulu nomsebenzi weselula kwingqondo ebonisa ukuba kunokwenzeka ukuba i-cannabis yezonyango ichaphazele umsebenzi we-neuron kubantwana abane-ASD. Ezi zinto zifunyanisiweyo ziqhubela phambili nenkqubela phambili yenkampani ekusungulweni kwenkonzo yeyeza lomntu ngamnye njengesixhobo kubaboneleli bezempilo kunye nezigulana ezifuna ukusebenzisa amayeza asekwe kwi-cannabinoid kunye neemveliso ukunyanga iimeko zonyango ezinzima.

Inkampani ipapashe iziphumo zayo kwijenali yeCannabis kunye noPhando lweCannabinoid kwiphepha elinesihloko esithi, "Izinto ezinokubakho ze-lipid-based-Responsive biomarkers zokuvavanya unyango lwe-cannabis kubantwana abane-ASD." Eli phepha liphepha lesibini eliphuma kuphononongo lwe-ASD Pilot yenkampani. Iphepha lokuqala elapapashwa ngoDisemba ka-2021 laseka i-Cannabis-Responsive biomarkers njengesixhobo sehlabathi sokulinganisa impembelelo ye-cannabis yonyango. Ngokudibeneyo la maphepha mabini abonisa amandla okuba i-Cannabis-Responsive biomarkers ibe sisixhobo kubo bobabini oogqirha abanyanga izigulane nge-cannabis yezonyango kunye neenkampani zesayensi yobomi eziphuhlisa isizukulwana esilandelayo amayeza asekwe kwi-cannabinoid kunye nokusetyenziswa.

Ngokuvula indlela yokusebenza ye-cannabis yezonyango, sibonisa ukuba i-Cannabis-Responsive biomarkers inokubonelela iinkampani zesayensi yobomi kunye noogqirha ngezixhobo ezitsha zokuqonda indima ye-cannabis ekugcineni i-homeostasis yenkqubo yemithambo-luvo kubantwana abane-ASD. Olu phononongo lukwavula amathuba amatsha okuvavanya unyango lwe-cannabis yezonyango kwizifo ze-neurodeergenerative ezifana nesifo se-Alzheimer, isifo sika-Parkinson kunye ne-ALS, apho ezinye zezi zinto zinokuthi zenzeke kwi-lipid-based Cannabis-Responsive biomarkers ziyaziwa ngokudlala indima, "utshilo u-Itzhak Kurek, PhD. , I-CEO kunye nomseki weCannformatics. "Ngoku sikwimeko yokunyusa inkunzi efunekayo ukuze kusungulwe iqonga lenkonzo ye-ASD kunye nokwanda kwizifo ze-neurodeergenerative."

"Ukupapashwa kweli phepha lesibini lixesha elibalulekileyo kwiCannformatics njengoko liqinisekisa ngokupheleleyo itekhnoloji yethu kwaye lisibeka ngokucacileyo njengenkokeli yebhayoloji kunyango lwe-cannabis," utshilo uKenneth Epstein iGosa eliyiNtloko lezoRhwebo kunye nomseki weCannformatics. “Sithe gqolo ukuba nombulelo kubantwana nakwiintsapho ezithathe inxaxheba kolu phando kwakunye nabaxhasi bethu kwiCanniatric neWhole Plant Access for Autism. Iziphumo zolu phononongo zihambe ngaphaya koko besikulindele.”

Malunga nombhali

IAvatar kaLinda Hohnholz

Linda Hohnholz

Umhleli oyintloko we eTurboNews esekwe kwi-eTN HQ.

Bhlisa
Yaziswe ngawo
guest
0 izimvo
Inline feedbacks
Jonga zonke izimvo
0
Ndingazithanda iingcinga zakho, nceda uphawule.x
Yabelana ku...